Table S3: Architecture of the LßT2
RUF-ZAMOJSKI, Frederique, et al. Regulatory architecture of the LβT2 gonadotrope cell underlying the response to gonadotropin-releasing hormone. Frontiers in endocrinology, 2018, 9. Jg., S. 34.
Publication: https://www.frontiersin.org/articles/10.3389/fendo.2018.00034/full
Description
Disclaimer
The publication Regulatory Architecture of the LβT2 Gonadotrope Cell Underlying the Response to Gonadotropin-Releasing Hormone by Frederique Ruf-Zamojski, Miguel Fribourg, Yongchao Ge, Venugopalan Nair, Hanna Pincas, Elena Zaslavsky, German Nudelman, Stephanie J. Tuminello, Hideo Watanabe, Judith L. Turgeon and Stuart C. Sealfon is published under an open access license: https://creativecommons.org/licenses/by/4.0/. Granted rights: share — copy and redistribute the material in any medium or format and adapt — remix, transform, and build upon the material for any purpose, even commercially.
Curation by the MFGA team
Pie chart of selected column
Table
| GENE | Pathways.processes.diseases | Database.my.gene.sets.gene.ontology.kegg | Freq...network.vs..genome. | P.value..fdr.corrected. |
|---|---|---|---|---|
| CDKN1C | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| EGR3 | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| FGFR3 | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| FOS | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| NR4A1 | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| JUN | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| SFRP1 | GO-BP-0071363:cellular response to growth factor stimulus | Gene Ontology | 20.0% (7/35) 1.8% (168/9324) | 0.000878 |
| CDKN1C | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| EGR3 | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| FGFR3 | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| FOS | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| NR4A1 | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| JUN | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| SFRP1 | GO-BP-0070848:response to growth factor | Gene Ontology | 20.0% (7/35) 1.9% (177/9324) | 0.000829 |
| EGR3 | GO-BP-0044344:cellular response to fibroblast growth factor stimulus | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00185 |
| FGFR3 | GO-BP-0044344:cellular response to fibroblast growth factor stimulus | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00185 |
| NR4A1 | GO-BP-0044344:cellular response to fibroblast growth factor stimulus | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00185 |
| SFRP1 | GO-BP-0044344:cellular response to fibroblast growth factor stimulus | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00185 |
| EGR3 | GO-BP-0071774:response to fibroblast growth factor | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00148 |
| FGFR3 | GO-BP-0071774:response to fibroblast growth factor | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00148 |
| NR4A1 | GO-BP-0071774:response to fibroblast growth factor | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00148 |
| SFRP1 | GO-BP-0071774:response to fibroblast growth factor | Gene Ontology | 11.4% (4/35) 0.4% (37/9324) | 0.00148 |
| ATF3 | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| CREBBP | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| EGR1 | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| EGR2 | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| FOS | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| JUN | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| ZFP36 | KEGG-Pathway-hsa05166: HTLV-I infection - Homo sapiens (human) | KEGG | 20.0% (7/35) 2.8% (263/9324) | 0.00548 |
| EFNB2 | GO-BP-0002042:cell migration involved in sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.2% (19/9324) | 0.00473 |
| EGR3 | GO-BP-0002042:cell migration involved in sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.2% (19/9324) | 0.00473 |
| NR4A1 | GO-BP-0002042:cell migration involved in sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.2% (19/9324) | 0.00473 |
| CDKN1C | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| EGR3 | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| FGFR3 | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| FOS | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| NR4A1 | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| JUN | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| SFRP1 | GO-BP-0071495:cellular response to endogenous stimulus | Gene Ontology | 20.0% (7/35) 3.0% (278/9324) | 0.00585 |
| FOS | KEGG-Pathway-hsa04380: Osteoclast differentiation - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.4% (132/9324) | 0.00992 |
| FOSB | KEGG-Pathway-hsa04380: Osteoclast differentiation - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.4% (132/9324) | 0.00992 |
| FOSL2 | KEGG-Pathway-hsa04380: Osteoclast differentiation - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.4% (132/9324) | 0.00992 |
| JUN | KEGG-Pathway-hsa04380: Osteoclast differentiation - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.4% (132/9324) | 0.00992 |
| JUNB | KEGG-Pathway-hsa04380: Osteoclast differentiation - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.4% (132/9324) | 0.00992 |
| EFNB2 | GO-BP-0002040:sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.3% (28/9324) | 0.0109 |
| EGR3 | GO-BP-0002040:sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.3% (28/9324) | 0.0109 |
| NR4A1 | GO-BP-0002040:sprouting angiogenesis | Gene Ontology | 8.6% (3/35) 0.3% (28/9324) | 0.0109 |
| CREBBP | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| NFIL3 | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| PITX2 | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| ZFP36 | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| BHLHE40 | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| CITED2 | GO-BP-0000122:negative regulation of transcription from RNA polymerase II promoter | Gene Ontology | 17.1% (6/35) 2.4% (225/9324) | 0.0111 |
| CREBBP | KEGG-Pathway-hsa05161: Hepatitis B - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.6% (146/9324) | 0.012 |
| EGR2 | KEGG-Pathway-hsa05161: Hepatitis B - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.6% (146/9324) | 0.012 |
| EGR3 | KEGG-Pathway-hsa05161: Hepatitis B - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.6% (146/9324) | 0.012 |
| FOS | KEGG-Pathway-hsa05161: Hepatitis B - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.6% (146/9324) | 0.012 |
| JUN | KEGG-Pathway-hsa05161: Hepatitis B - Homo sapiens (human) | KEGG | 14.3% (5/35) 1.6% (146/9324) | 0.012 |
| CDKN1C | GO-BP-0071559:response to transforming growth factor beta | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0116 |
| FOS | GO-BP-0071559:response to transforming growth factor beta | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0116 |
| JUN | GO-BP-0071559:response to transforming growth factor beta | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0116 |
| SFRP1 | GO-BP-0071559:response to transforming growth factor beta | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0116 |
| CDKN1C | GO-BP-0071560:cellular response to transforming growth factor beta stimulus | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0107 |
| FOS | GO-BP-0071560:cellular response to transforming growth factor beta stimulus | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0107 |
| JUN | GO-BP-0071560:cellular response to transforming growth factor beta stimulus | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0107 |
| SFRP1 | GO-BP-0071560:cellular response to transforming growth factor beta stimulus | Gene Ontology | 11.4% (4/35) 0.8% (79/9324) | 0.0107 |
| DUSP1 | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| DUSP5 | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| FGFR3 | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| FOS | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| NR4A1 | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| JUN | KEGG-Pathway-hsa04010: MAPK signaling pathway - Homo sapiens (human) | KEGG | 17.1% (6/35) 2.8% (259/9324) | 0.0175 |
| ZFP36 | GO-BP-0000289:nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0173 |
| BTG2 | GO-BP-0000289:nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0173 |
| ZFP36 | GO-BP-0060211:regulation of nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0163 |
| BTG2 | GO-BP-0060211:regulation of nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0163 |
| ZFP36 | GO-BP-1900151:regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0154 |
| BTG2 | GO-BP-1900151:regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0154 |
| ZFP36 | GO-BP-0060213:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0146 |
| BTG2 | GO-BP-0060213:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | Gene Ontology | 5.7% (2/35) 0.1% (8/9324) | 0.0146 |
| EFNB2 | GO-BP-0043534:blood vessel endothelial cell migration | Gene Ontology | 8.6% (3/35) 0.4% (40/9324) | 0.016 |
| EGR3 | GO-BP-0043534:blood vessel endothelial cell migration | Gene Ontology | 8.6% (3/35) 0.4% (40/9324) | 0.016 |
| NR4A1 | GO-BP-0043534:blood vessel endothelial cell migration | Gene Ontology | 8.6% (3/35) 0.4% (40/9324) | 0.016 |
| EGR3 | GO-BP-0035767:endothelial cell chemotaxis | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0211 |
| NR4A1 | GO-BP-0035767:endothelial cell chemotaxis | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0211 |
| ZFP36 | GO-BP-0061014:positive regulation of mRNA catabolic process | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0202 |
| BTG2 | GO-BP-0061014:positive regulation of mRNA catabolic process | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0202 |
| FOS | GO-BP-0060395:SMAD protein signal transduction | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0193 |
| JUN | GO-BP-0060395:SMAD protein signal transduction | Gene Ontology | 5.7% (2/35) 0.1% (10/9324) | 0.0193 |
| CDKN1C | GO-BP-0050678:regulation of epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.1% (106/9324) | 0.0193 |
| EGR3 | GO-BP-0050678:regulation of epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.1% (106/9324) | 0.0193 |
| NR4A1 | GO-BP-0050678:regulation of epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.1% (106/9324) | 0.0193 |
| SFRP1 | GO-BP-0050678:regulation of epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.1% (106/9324) | 0.0193 |
| CEBPB | KEGG-Pathway-hsa04668: TNF signaling pathway - Homo sapiens (human) | KEGG | 11.4% (4/35) 1.2% (110/9324) | 0.0213 |
| FOS | KEGG-Pathway-hsa04668: TNF signaling pathway - Homo sapiens (human) | KEGG | 11.4% (4/35) 1.2% (110/9324) | 0.0213 |
| JUN | KEGG-Pathway-hsa04668: TNF signaling pathway - Homo sapiens (human) | KEGG | 11.4% (4/35) 1.2% (110/9324) | 0.0213 |
| JUNB | KEGG-Pathway-hsa04668: TNF signaling pathway - Homo sapiens (human) | KEGG | 11.4% (4/35) 1.2% (110/9324) | 0.0213 |
| ZFP36 | GO-BP-0061013:regulation of mRNA catabolic process | Gene Ontology | 5.7% (2/35) 0.1% (11/9324) | 0.0208 |
| BTG2 | GO-BP-0061013:regulation of mRNA catabolic process | Gene Ontology | 5.7% (2/35) 0.1% (11/9324) | 0.0208 |
| ZFP36 | GO-BP-0031442:positive regulation of mRNA 3-end processing | Gene Ontology | 5.7% (2/35) 0.1% (12/9324) | 0.024 |
| BTG2 | GO-BP-0031442:positive regulation of mRNA 3-end processing | Gene Ontology | 5.7% (2/35) 0.1% (12/9324) | 0.024 |
| ZFP36 | GO-BP-0031440:regulation of mRNA 3-end processing | Gene Ontology | 5.7% (2/35) 0.1% (12/9324) | 0.0231 |
| BTG2 | GO-BP-0031440:regulation of mRNA 3-end processing | Gene Ontology | 5.7% (2/35) 0.1% (12/9324) | 0.0231 |
| CDKN1C | GO-BP-0050673:epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.3% (121/9324) | 0.0262 |
| EGR3 | GO-BP-0050673:epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.3% (121/9324) | 0.0262 |
| NR4A1 | GO-BP-0050673:epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.3% (121/9324) | 0.0262 |
| SFRP1 | GO-BP-0050673:epithelial cell proliferation | Gene Ontology | 11.4% (4/35) 1.3% (121/9324) | 0.0262 |
| ZFP36 | GO-BP-0000288:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | Gene Ontology | 5.7% (2/35) 0.2% (14/9324) | 0.0296 |
| BTG2 | GO-BP-0000288:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | Gene Ontology | 5.7% (2/35) 0.2% (14/9324) | 0.0296 |
| CDKN1C | GO-BP-0007179:transforming growth factor beta receptor signaling pathway | Gene Ontology | 8.6% (3/35) 0.7% (61/9324) | 0.0356 |
| FOS | GO-BP-0007179:transforming growth factor beta receptor signaling pathway | Gene Ontology | 8.6% (3/35) 0.7% (61/9324) | 0.0356 |
| JUN | GO-BP-0007179:transforming growth factor beta receptor signaling pathway | Gene Ontology | 8.6% (3/35) 0.7% (61/9324) | 0.0356 |
| EGR3 | GO-BP-0050679:positive regulation of epithelial cell proliferation | Gene Ontology | 8.6% (3/35) 0.7% (62/9324) | 0.0361 |
| NR4A1 | GO-BP-0050679:positive regulation of epithelial cell proliferation | Gene Ontology | 8.6% (3/35) 0.7% (62/9324) | 0.0361 |
| SFRP1 | GO-BP-0050679:positive regulation of epithelial cell proliferation | Gene Ontology | 8.6% (3/35) 0.7% (62/9324) | 0.0361 |
| ZFP36 | GO-BP-0050685:positive regulation of mRNA processing | Gene Ontology | 5.7% (2/35) 0.2% (17/9324) | 0.04 |
| BTG2 | GO-BP-0050685:positive regulation of mRNA processing | Gene Ontology | 5.7% (2/35) 0.2% (17/9324) | 0.04 |
| FOS | KEGG-Pathway-hsa05031: Amphetamine addiction - Homo sapiens (human) | KEGG | 8.6% (3/35) 0.7% (68/9324) | 0.0444 |
| FOSB | KEGG-Pathway-hsa05031: Amphetamine addiction - Homo sapiens (human) | KEGG | 8.6% (3/35) 0.7% (68/9324) | 0.0444 |
| JUN | KEGG-Pathway-hsa05031: Amphetamine addiction - Homo sapiens (human) | KEGG | 8.6% (3/35) 0.7% (68/9324) | 0.0444 |
| SFRP1 | GO-BP-0048511:rhythmic process | Gene Ontology | 5.7% (2/35) 0.2% (19/9324) | 0.0472 |
| BHLHE40 | GO-BP-0048511:rhythmic process | Gene Ontology | 5.7% (2/35) 0.2% (19/9324) | 0.0472 |
| EFNB2 | GO-BP-0072359:circulatory system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.0472 |
| EGR3 | GO-BP-0072359:circulatory system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.0472 |
| NR4A1 | GO-BP-0072359:circulatory system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.0472 |
| MYLK | GO-BP-0072359:circulatory system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.0472 |
| CITED2 | GO-BP-0072359:circulatory system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.0472 |
| EFNB2 | GO-BP-0072358:cardiovascular system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.046 |
| EGR3 | GO-BP-0072358:cardiovascular system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.046 |
| NR4A1 | GO-BP-0072358:cardiovascular system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.046 |
| MYLK | GO-BP-0072358:cardiovascular system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.046 |
| CITED2 | GO-BP-0072358:cardiovascular system development | Gene Ontology | 14.3% (5/35) 2.7% (252/9324) | 0.046 |
| EFNB2 | GO-BP-0048514:blood vessel morphogenesis | Gene Ontology | 11.4% (4/35) 1.6% (153/9324) | 0.0475 |
| EGR3 | GO-BP-0048514:blood vessel morphogenesis | Gene Ontology | 11.4% (4/35) 1.6% (153/9324) | 0.0475 |
| NR4A1 | GO-BP-0048514:blood vessel morphogenesis | Gene Ontology | 11.4% (4/35) 1.6% (153/9324) | 0.0475 |
| MYLK | GO-BP-0048514:blood vessel morphogenesis | Gene Ontology | 11.4% (4/35) 1.6% (153/9324) | 0.0475 |
| NR4A2 | GO-BP-0009991:response to extracellular stimulus | Gene Ontology | 8.6% (3/35) 0.8% (73/9324) | 0.0474 |
| SFRP1 | GO-BP-0009991:response to extracellular stimulus | Gene Ontology | 8.6% (3/35) 0.8% (73/9324) | 0.0474 |
| ZFP36 | GO-BP-0009991:response to extracellular stimulus | Gene Ontology | 8.6% (3/35) 0.8% (73/9324) | 0.0474 |